Evidence map›Paper›PMID 28314374›Full record

ArticleAIDS research and human retroviruses2017

HIV-1 Consensus Envelope-Induced Broadly Binding Antibodies.

R Ryan Meyerhoff, Richard M Scearce, Damon F Ogburn, Brad Lockwood, Joy Pickeral, Masa Kuraoka, Kara Anasti, Joshua Eudailey, Amanda Eaton, Melissa Cooper and 9 more

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 2 countries.

R Ryan Meyerhoff1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Richard M Scearce1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Damon F Ogburn1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Brad Lockwood1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Joy Pickeral1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Masa Kuraoka2 Department of Immunology, Duke University School of Medicine , Durham, North Carolina.
Kara Anasti1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Joshua Eudailey1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Amanda Eaton1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Melissa Cooper1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Kevin Wiehe1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
David C Montefiori1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Georgia Tomaras1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Guido Ferrari1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
S Munir Alam1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Hua-Xin Liao1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Bette Korber5 Los Alamos National Laboratory , Los Alamos, New Mexico .
Feng Gao1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Barton F Haynes1 Duke Human Vaccine Institute, Duke University School of Medicine , Durham, North Carolina.
Duke University · USJinan University · CNLos Alamos National Laboratory · US

Funding

Virus biology scientific research support componentUM1AI100645 · NIAID · DUKE UNIVERSITY · PI SANTRA, SAMPA · 2012 to 2018
$204.7M
Virus and Antibody Gene Sequencing CoreP01AI131251 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI GEORGE M SHAW · 2017 to 2026
$40.7M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007171 · NIGMS · DUKE UNIVERSITY · PI KONTOS, CHRISTOPHER D · 1985 to 2021
$31.2M
Medical Scientist Training Program Training GrantT32GM145449 · NIGMS · DUKE UNIVERSITY · PI Christopher D Kontos · 2022 to 2026
$6.6M
Novel mouse model of HIV broad neutralizing antibody inductionF30AI122982 · NIAID · DUKE UNIVERSITY · PI MEYERHOFF, ROBERT RYAN · 2016 to 2017
$79k
NIAID NIH HHS F30 AI122982NIAID NIH HHS P01 AI131251NIAID NIH HHS UM1 AI100645NIGMS NIH HHS T32 GM007171NIGMS NIH HHS T32 GM145449
6 · The paper itself

Abstract

Antibodies that cross-react with multiple HIV-1 envelopes (Envs) are useful reagents for characterizing Env proteins and for soluble Env capture and purification assays. We previously reported 10 murine monoclonal antibodies induced by group M consensus Env, CON-6 immunization. Each demonstrated broad cross-reactivity to recombinant Envs. Here we characterized the Env epitopes to which they bind. Seven mapped to linear epitopes in gp120, five at the Env N-terminus, and two at the Env C-terminus. One antibody, 13D7, bound at the gp120 N-terminus (aa 30-42), reacted with HIV-1-infected CD4

Indexed as

Consensus SequenceAIDS VaccinesAnimalsAntibodies, MonoclonalAntibody-Dependent Cell Cytotoxicityenv Gene Products, Human Immunodeficiency VirusEpitope MappingEpitopesHIV-1HIV AntibodiesMice, Inbred BALB CAIDS VaccinesAntibodies, Monoclonalenv Gene Products, Human Immunodeficiency VirusEpitopesHIV AntibodiesADCCantibody-mediated immunityHIVmonoclonalvaccine design

Identifiers

PMID28314374
PMCPMC5564029
OpenAlexW2595903937

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.